133 -6 (80) 2025 - Boborakhimova U.M. - PERSONALISED APPROACH TO CONTRACEPTIVE USE IN WOMEN WITH SOMATIC DISORDERS

PERSONALISED APPROACH TO CONTRACEPTIVE USE IN WOMEN WITH SOMATIC DISORDERS

Boborakhimova U.M. - Samarkand State Medical University

Resume

Modern contraception offers a wide range of methods for preventing unwanted pregnancy, but the selection of the optimal method for women with somatic pathology requires special attention. The purpose of this work is to consider the principles of a personalized approach to choosing contraceptives, taking into account the individual clinical and functional characteristics of women suffering from somatic diseases. Particular attention is paid to the interaction of hormonal contraceptives with chronic diseases of the cardiovascular, hepatobiliary, endocrine and autoimmune systems, as well as to the assessment of risks and contraindications. The article presents modern clinical guidelines, algorithms for choosing a contraceptive method and approaches to counseling patients taking into account their age, reproductive plans, the presence of risk factors and drug interactions. A personalized approach can increase the safety and effectiveness of contraception, as well as improve the quality of life of women with somatic disorders

Key words : Obesity, Reproductive health, personalized approach physical activity, medication, contraindications to contraception, risk assessment, medical eligibility criteria (MEC, WHO)

First page

612

Last page

617

For citation:Boborakhimova U.M. - PERSONALISED APPROACH TO CONTRACEPTIVE USE IN WOMEN WITH SOMATIC DISORDERS//New Day in Medicine 6(80)2025 612-617 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Abdullaeva L.M., Agababyan L.R., Boborakhimova U. Hormonal contraception - advantages and disadvantages
  2. Abdullaeva L.M., Agababyan L.R., Boborakhimova U., Excess body weight in women of reproductive age and methods of its correction.
  3. Abdullaeva L. M., Boborakhimova U. M., Agababyan L. R. Program for calculating the acceptability of combined oral contraception in obese women
  4. The Agency for Intellectual Property of the Republic of Uzbekistan notifies of the fact of receipt of application documents for registration of the computer program “Program for calculating the acceptability of combined oral contraception in obese women”
  5. Ametov A.S. Effective treatment of obesity – a way to combat the epidemic of diabetes mellipedis. Medical Council. 2013; 2(2): 78-84.
  6. Ashurova N.G., Khamdamova M.T. Obesity as a risk factor for pregnancy and childbirth. Collection of materials of the republican scientific and practical conference, December 2-3, 2015, Bukhara, p.21
  7. Global status report on noncommunicable diseases. WHO; 2010.
  8. A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel / JM Foidart, W. Wuttke, GM Bouw et al. //Eur. J. Contracept. Reprod. Health Care, 2000.-Vol. 5, 2. P.-124-134.
  9. Prilepskaya V.N., Mezhevitinova E.A., Sasunova R.A., Ivanova E.V., Letunovskaya A.B., Nabieva K.R. Results of clinical use of a drug containing drospirenone in women with severe premenstrual syndrome. Obstetrics And gynecology . 2012; 2:81-5.
  10. CaprioM., A. AntelmiA. "Antiaadipogenic effect of Drospirenone: potential implications for the treatment of metabolic syndrome", 2011
  11. CaprioМ.,AntelmiА.Antiaadipogenic effect of the Mineralocorticoid Receptor Antagonist Drospirenon: Potential Implications for the Treatment of Metabolic Syndrome// Endocrinology, July 01, 2015, ISSN 1945-7170

    file

    download